DiviDrip · JAGX

JAGX — Jaguar Health, Inc.

JAGX is Jaguar Health, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.60. Market cap: $3M. Capital Quality Rank: 18/100 — Capital destroyer.

Stock snapshot

Price$0.60
Market cap$3M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)18 / 100 · Capital destroyer
Revenue CAGR (3y)-1.3%
Shareholder buyback yield-1.29%
Altman Z-score zoneDistress

About JAGX

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Listed2015Employees47HQSan Francisco, CASectorHealthcareWebsitejaguar.health

Related non-dividend companies

Other non-dividend stocks investors research alongside JAGX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is JAGX's current stock price?

JAGX (Jaguar Health, Inc.) is currently trading at $0.60.

Does JAGX pay a dividend?

JAGX (Jaguar Health, Inc.) does not currently pay a regular dividend.

What is JAGX's Capital Quality Rank?

JAGX has a Capital Quality Rank of 18/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track JAGX in DiviDrip

Add JAGX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow